HomeInsightsStock Comparison

Denis Chem Lab Ltd vs Marksans Pharma Ltd Stock Comparison

Denis Chem Lab Ltd vs Marksans Pharma Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Denis Chem Lab Ltd is ₹ 100 as of 22 Jul 11:59.
  • The P/E Ratio of Denis Chem Lab Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Marksans Pharma Ltd changed from 4.7 on March 2020 to 26.5 on March 2025 . This represents a CAGR of 33.41% over 6 years.
  • The Market Cap of Denis Chem Lab Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Marksans Pharma Ltd changed from ₹ 568.95 crore on March 2020 to ₹ 10076 crore on March 2025 . This represents a CAGR of 61.45% over 6 years.
  • The revenue of Denis Chem Lab Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Marksans Pharma Ltd for the Mar '25 is ₹ 724.98 crore as compare to the Dec '24 revenue of ₹ 709.7 crore. This represent the growth of 2.15%.
  • The ebitda of Denis Chem Lab Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Marksans Pharma Ltd for the Mar '25 is ₹ 142.27 crore as compare to the Dec '24 ebitda of ₹ 166.61 crore. This represent the decline of -14.61%.
  • The net profit of Denis Chem Lab Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Marksans Pharma Ltd changed from ₹ 70.44 crore to ₹ 90.73 crore over 8 quarters. This represents a CAGR of 13.49% .
  • The Dividend Payout of Denis Chem Lab Ltd changed from 46.06 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Marksans Pharma Ltd changed from 10.8 % on March 2020 to 19.26 % on March 2025 . This represents a CAGR of 10.12% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Denis Chem Lab Ltd

  • Denis Chem Lab Ltd, was incorporated in 1980 and was converted into a Public Limited Company in 1982.
  • The Company was registered with Directorate General of Technical Development (DGTD) for manufacturing 4 million bottles of I.V. Fluids and 75 MT of Bulk Drugs per annum and started commercial production for sterile Intravenous (IV) Injectibles in 1984 and also came up with a rights issue during the year In 1995, it ventured into manufacturing of IV Fluids in PP bottles using BFS technology. The Company is a manufacturer of antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti anaerobic injections, irrigation solutions etc.
  • It is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles.
  • The Company products are manufactured in ultra modern plant using automatic equipments and facilities, which are conforming to GMP specifications as per WHO norms.

About Marksans Pharma Ltd

  • Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982.
  • Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals Limited to Marksans Pharma Limited with effect from 10th October, 2005.
  • The Company primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation.
  • The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. In 2004-05, the Company amalgamated with M/s.
  • Marksans Pharma Limited (formerly M/s.

Denis Chem Lab Ltd News Hub

News

Board of Denis Chem Lab recommends final dividend

Denis Chem Lab announced that the Board of Directors of the Company at its meeting held on...

Read more

30 May 2025 15:59

News

Denis Chem Lab to hold board meeting

Denis Chem Lab will hold a meeting of the Board of Directors of the Company on 30 May 2025...

Read more

20 May 2025 17:22

News

Denis Chem Lab to discuss results

Denis Chem Lab will hold a meeting of the Board of Directors of the Company on 14 February...

Read more

03 Feb 2025 10:37

News

Denis Chem Lab to table results

Denis Chem Lab will hold a meeting of the Board of Directors of the Company on 14 November...

Read more

02 Nov 2024 14:01

News

Denis Chem Lab to conduct board meeting

Denis Chem Lab will hold a meeting of the Board of Directors of the Company on 14 November...

Read more

30 Oct 2024 17:23

News

Denis Chem Lab to hold board meeting

Denis Chem Lab will hold a meeting of the Board of Directors of the Company on 14 August 2...

Read more

03 Aug 2024 14:32

Marksans Pharma Ltd News Hub

News

Marksans Pharma AGM scheduled

Marksans Pharma announced that the 33th Annual General Meeting(AGM) of the company will be...

Read more

11 Jul 2025 17:41

News

Time-Cap Laboratories successfully concludes USFDA inspection

Marksans Pharma announced that its subsidiary, Time-Cap Laboratories Inc. has received the...

Read more

30 Jun 2025 12:56

News

Marksans Pharma rises after subsidiary gets EIR for New York-based facility from US FDA

In April this year, the United States Food and Drug Administration (US FDA) had conducted ...

Read more

30 Jun 2025 12:58

News

Marksans Pharma's UK arm gets marketing nod for Oxybutynin Oral solution from UKMHRA

Oxybutynin is used in the treatment of overactive bladder (OAB) symptoms. OAB is a collect...

Read more

19 Jun 2025 10:04

News

Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

30 May 2025 09:13

News

Marksans Pharma gets regulatory nod for marketing type-2 diabetes medication in UK

Metformin Hydrochloride is a widely prescribed medication used for the management of type-...

Read more

30 May 2025 09:33

SWOT Analysis Of Marksans Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Denis Chem Lab Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Marksans Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Denis Chem Lab Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Denis Chem Lab Ltd and Marksans Pharma Ltd

Which company has a larger market capitalization, Denis Chem Lab Ltd or Marksans Pharma Ltd?

Market cap of Denis Chem Lab Ltd is 138 Cr while Market cap of Marksans Pharma Ltd is 11,209 Cr

What are the key factors driving the stock performance of Denis Chem Lab Ltd and Marksans Pharma Ltd?

The stock performance of Denis Chem Lab Ltd and Marksans Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Denis Chem Lab Ltd and Marksans Pharma Ltd?

As of July 22, 2025, the Denis Chem Lab Ltd stock price is INR ₹100.05. On the other hand, Marksans Pharma Ltd stock price is INR ₹247.35.

How do dividend payouts of Denis Chem Lab Ltd and Marksans Pharma Ltd compare?

To compare the dividend payouts of Denis Chem Lab Ltd and Marksans Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions